Yie, Kilsoo <br/><br/>
Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR).  [electronic resource] 

 -  Perfusion  May 2016 
 - 307-15 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1477-111X 
<br/><br/><label>Standard No.: </label>10.1177/0267659115604710  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cardiopulmonary Resuscitation<br/>Extracorporeal Membrane Oxygenation<br/>Female<br/>Heparin--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Partial Thromboplastin Time<br/>Whole Blood Coagulation Time